This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3omk
From Proteopedia
(Difference between revisions)
OCA (Talk | contribs)
(New page: '''Unreleased structure''' The entry 3omk is ON HOLD Authors: Rudolph, M.G. Description: Lead optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists f...)
Next diff →
Revision as of 07:28, 15 September 2010
Unreleased structure
The entry 3omk is ON HOLD
Authors: Rudolph, M.G.
Description: Lead optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists for improved physicochemical and ADME properties
Page seeded by OCA on Wed Sep 15 10:37:25 2010
